1. Home
  2. MIRA vs BREA Comparison

MIRA vs BREA Comparison

Compare MIRA & BREA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIRA
  • BREA
  • Stock Information
  • Founded
  • MIRA 2020
  • BREA 2022
  • Country
  • MIRA United States
  • BREA Ireland
  • Employees
  • MIRA N/A
  • BREA N/A
  • Industry
  • MIRA Biotechnology: Pharmaceutical Preparations
  • BREA Services-Misc. Amusement & Recreation
  • Sector
  • MIRA Health Care
  • BREA Consumer Discretionary
  • Exchange
  • MIRA Nasdaq
  • BREA Nasdaq
  • Market Cap
  • MIRA 19.5M
  • BREA 13.6M
  • IPO Year
  • MIRA 2023
  • BREA 2023
  • Fundamental
  • Price
  • MIRA $1.22
  • BREA $7.43
  • Analyst Decision
  • MIRA Strong Buy
  • BREA
  • Analyst Count
  • MIRA 2
  • BREA 0
  • Target Price
  • MIRA $14.00
  • BREA N/A
  • AVG Volume (30 Days)
  • MIRA 191.4K
  • BREA 18.9K
  • Earning Date
  • MIRA 08-12-2025
  • BREA 01-03-2025
  • Dividend Yield
  • MIRA N/A
  • BREA N/A
  • EPS Growth
  • MIRA N/A
  • BREA N/A
  • EPS
  • MIRA N/A
  • BREA N/A
  • Revenue
  • MIRA N/A
  • BREA $2,988,009.00
  • Revenue This Year
  • MIRA N/A
  • BREA N/A
  • Revenue Next Year
  • MIRA N/A
  • BREA N/A
  • P/E Ratio
  • MIRA N/A
  • BREA N/A
  • Revenue Growth
  • MIRA N/A
  • BREA 151.51
  • 52 Week Low
  • MIRA $0.51
  • BREA $5.00
  • 52 Week High
  • MIRA $5.01
  • BREA $19.50
  • Technical
  • Relative Strength Index (RSI)
  • MIRA 46.79
  • BREA 57.22
  • Support Level
  • MIRA $1.18
  • BREA $5.90
  • Resistance Level
  • MIRA $1.26
  • BREA $7.78
  • Average True Range (ATR)
  • MIRA 0.07
  • BREA 0.69
  • MACD
  • MIRA -0.01
  • BREA 0.06
  • Stochastic Oscillator
  • MIRA 31.58
  • BREA 83.82

About MIRA MIRA Pharmaceuticals Inc.

Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

About BREA Brera Holdings PLC

Brera Holdings PLC focused on expanding social impact football by developing a international portfolio of emerging football clubs with increased opportunities to earn tournament prizes, gain sponsorships, and provide other professional football and related consulting services.

Share on Social Networks: